GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] triple agonist — what am I missing here — 45 comments in the full submission. View in context.
1.6k
c/retatrutide·submitted 10 months ago by u/incretin_ivy

[Question] triple agonist — what am I missing here

Questionbranch of 5 comments

Been lurking in c/sideeffects for about 7 months and finally have something worth posting. Short version: week 42, 15mg, and triple agonist is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 19 threads, and the answers split roughly down the middle. What I actually want to…

Read the full submission and all 45 comments →

This branch

5 comments, started 10 months ago
u/kavya_kravchenko168 points·10 months ago

TRIUMPH phase 2 showed 99.3% weight loss but the nausea profile on the highest arm was rough. Phase 2 != phase 3.

replysharereportpermalink
u/ledger_modMOD95 points·10 months ago

Flair changed to match the content. Read the sidebar before posting next time and we are square.

replysharereportpermalink
[removed]37 points·10 months ago

[removed by moderator]

replysharereportpermalink
u/incretin_ivyOPpharmacology72 points·10 months ago

the weight curves are unusually steep, which makes predicting individual response harder

replysharereportpermalink
u/helga_vermeulen45 points·10 months ago

triple agonism is phase 2, do not generalise

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.